Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CARBOCISTEINE
Sanofi-Aventis Ireland Limited T/A SANOFI
R05CB03
CARBOCISTEINE
250 MG/5ml
Syrup
Product not subject to medical prescription
Mucolytics
Transfer Pending
1999-09-24
Reference: 4490 1.3.1.3 - Leaflet Text - PIL - 250mg/5ml - 2015-10-07 - 0000 - GLUv5 3.2 PACKAGE LEAFLET: INFORMATION FOR THE USER MUCODYNE SYRUP 250 MG/5 ML Carbocisteine IS THIS LEAFLET HARD TO SEE OR READ? PHONE 01 403 5600 FOR HELP READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the leaflet. IN THIS LEAFLET: 1. WHAT MUCODYNE SYRUP IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MUCODYNE SYRUP 3. HOW TO TAKE MUCODYNE SYRUP 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE MUCODYNE SYRUP 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT MUCODYNE SYRUP IS AND WHAT IT IS USED FOR Mucodyne Syrup 250 mg/5 ml (called Mucodyne Syrup in this leaflet) contains a medicine called carbocisteine. This belongs to a group of medicines called ‘mucolytics’. It works by making mucus (phlegm) less sticky. This makes the mucus easier to cough up. Mucodyne Syrup is used for problems with the breathing passages (respiratory tract). These problems happen when too much mucus is made or the mucus is too sticky. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MUCODYNE SYRUP DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: You are allergic (hypersensitive) to carbocisteine or any of the other ingredients of Mucodyne Syrup (listed in Section 6 below). Signs of an allergic reaction include: a rash, swallowing or breat Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mucodyne Syrup 250 mg/5 ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml contains 250 mg of Carbocisteine. Each 5ml also contains sucrose 2g and Methyl Parahydroxybenzoate (E218) 7.5mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Syrup. An amber coloured syrup with an odour of cinnamon and rum. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive or viscous mucus. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The route of administration is oral. RECOMMENDED DOSAGE: ADULTS: The usual dose is 15ml three times daily initially, reducing to 10ml three times daily when a satisfactory response has been obtained. CHILDREN: The usual daily dose is 20mg/kg in divided doses. The paediatric preparation should be used. 4.3 CONTRAINDICATIONS 1. Use in patients with a known hypersensitivity to Carbocisteine. 2. Use in patients with active peptic ulceration. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Caution is recommended in the elderly, in those with a history of gastroduodenal ulcers, or those taking concomitant medications known to cause gastrointestinal bleeding. If gastrointestinal bleeding occurs, patients should discontinue medication. Because of the possible effect on the mucous glands of the stomach, this product should be used with caution in patients with a history of peptic ulceration. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 11/02/2016_ _CRN 2169091_ _page number: 1_ Mucodyne Syrup is unsuitable for those patients who have inherited fructose intolerance, glucose-galactose m Read the complete document